Research Articles
The Triple Threat: Could Combining Vedolizumab, Ustekinumab, and Tofacitinib Revolutionize Ulcerative Colitis Treatment?
Exploring the potential of vedolizumab, ustekinumab, and tofacitinib triple therapy for ulcerative colitis treatment through mechanisms, evidence, and future directions.
Beyond the Usual Suspects: New Hope for Severe Ulcerative Colitis
Exploring non-anti-TNF biologics as salvage therapy for refractory acute severe ulcerative colitis, including vedolizumab, ustekinumab, and novel small molecule therapies.